13 articles
Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO's decision on double patenting, updates from…
India and Japan will act as competent ISA and IPEA for each other's PCT filings from July 2021. Apple faces a $308.5 million patent infringement fine, while the…
This post reports on major patent developments, including IBM and Samsung's US patent rankings for 2020 and the ITC's decision in favour of Garmin over Philips. It also…
The CPI(M) has urged the Indian government to issue a compulsory license for Remdesivir to facilitate generic manufacturing. Additionally, the EPO has developed new patent search strategies for…
The post analyses patent law updates relating to COVID-19, including India’s push for TRIPS flexibilities and scrutiny of Gilead’s Remdesvir patent. It also covers the EPO’s stance on…
The Central Government is set to establish the National Startup Advisory Council to enhance India’s startup ecosystem and support IP protection. This week’s bulletin also covers major patent…
The EPO has ruled that machines cannot be recognized as inventors, marking a significant stance in patent law. Toyota launches an IP Licensing Program, while Michelin pursues a…
The Union Cabinet’s approval of the Patent Prosecution Highway with Japan marks a notable step for faster patents in India, especially for startups and MSMEs. Additional highlights include…
This post reviews the development of the Cooperative Patent Classification system by the EPO and USPTO to streamline patent classification globally. It addresses the challenges of using multiple…
This update examines key patent news including Indian patent statistics, infringement cases against major tech firms, and international developments at the EPO and in China. It also covers…